2012

• Trask, A.J.; Delbin, M.A.; Katz, P.S.; Zanesco, A. et al., 2012, "Differential coronary resistance microvessel remodeling between type 1 and type 2 diabetic mice: Impact of exercise training." VASCULAR PHARMACOLOGY 57, no. 5-6,
• Trask, A.J.; Katz, P.S.; Kelly, A.P.; Galantowicz, M.L. et al., 2012, "Dynamic micro- and macrovascular remodeling in coronary circulation of obese Ossabaw pigs with metabolic syndrome." JOURNAL OF APPLIED PHYSIOLOGY 113, no. 7,
• Groban, L.; Wang, H.; Machado, F.S.; Trask, A.J. et al., 2012, Low glial angiotensinogen improves body habitus, diastolic function, and exercise tolerance in aging male rats. Cardiovasc Endocrinol 1, no. 3,

2011

• Egan, M.J.; Trask, A.J.; Baker, P.B.; Lawrence, J. et al., 2011, Histopathologic evaluation of patent ductus arteriosus stents after hybrid stage I palliation. Pediatr Cardiol 32, no. 4,
• Katz, P.S.; Trask, A.J.; Souza-Smith, F.M.; Hutchinson, K.R. et al., 2011, Coronary arterioles in type 2 diabetic (db/db) mice undergo a distinct pattern of remodeling associated with decreased vessel stiffness. Basic Res Cardiol 106, no. 6,
• Souza-Smith, F.M.; Katz, P.S.; Trask, A.J.; Stewart, J.A. et al., 2011, Mesenteric resistance arteries in type 2 diabetic db/db mice undergo outward remodeling. PLoS One 6, no. 8,

2010

• Trask, A.J.; Groban, L.; Westwood, B.M.; Varagic, J. et al., 2010, Inhibition of angiotensin-converting enzyme 2 exacerbates cardiac hypertrophy and fibrosis in Ren-2 hypertensive rats. Am J Hypertens 23, no. 6,

2009

• Ferrario, C.M.; Varagic, J.; Habibi, J.; Nagata, S. et al., 2009, Differential regulation of angiotensin-(1-12) in plasma and cardiac tissue in response to bilateral nephrectomy. Am J Physiol Heart Circ Physiol 296, no. 4,
• Katz, P.S.; Trask, A.J.; Lucchesi, P.A., 2009, Curcuminoids: Spicing up sympathovagal tone. Nutrition 25, no. 7-8,

2008

• Jessup, J.A.; Trask, A.J.; Chappell, M.C.; Nagata, S. et al., 2008, Localization of the novel angiotensin peptide, angiotensin-(1-12), in heart and kidney of hypertensive and normotensive rats. Am J Physiol Heart Circ Physiol 294, no. 6,
• Trask, A.J.; Jessup, J.A.; Chappell, M.C.; Ferrario, C.M., 2008, Angiotensin-(1-12) is an alternate substrate for angiotensin peptide production in the heart. Am J Physiol Heart Circ Physiol 294, no. 5,
• Varagic, J.; Trask, A.J.; Jessup, J.A.; Chappell, M.C. et al., 2008, New angiotensins. J Mol Med (Berl) 86, no. 6,

2007

• Trask, A.J.; Averill, D.B.; Ganten, D.; Chappell, M.C. et al., 2007, Primary role of angiotensin-converting enzyme-2 in cardiac production of angiotensin-(1-7) in transgenic Ren-2 hypertensive rats. Am J Physiol Heart Circ Physiol 292, no. 6,
• Trask, A.J.; Ferrario, C.M., 2007, Angiotensin-(1-7): pharmacology and new perspectives in cardiovascular treatments. Cardiovasc Drug Rev 25, no. 2,

2005

• Ferrario, C.M.; Trask, A.J.; Jessup, J.A., 2005, Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function. Am J Physiol Heart Circ Physiol 289, no. 6,

Unknown

• Delbin, M.A.; Trask, A.J., "The Diabetic Vasculature: Physiological Mechanisms of Dysfunction and Influence of Aerobic Exercise Training in Animal Models." Life Sciences